This cross-sectional study of health claims from patients with private insurance examines trends in the cost of entecavir prescribed for chronic hepatitis B treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783269PMC
http://dx.doi.org/10.1001/jamanetworkopen.2021.44521DOI Listing

Publication Analysis

Top Keywords

trends pricing
4
pricing out-of-pocket
4
out-of-pocket spending
4
spending entecavir
4
entecavir commercially
4
commercially insured
4
insured patients
4
patients 2014-2018
4
2014-2018 cross-sectional
4
cross-sectional study
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!